Previous Close | 0.4270 |
Open | 0.4200 |
Bid | 0.4080 x 3000 |
Ask | 0.4085 x 900 |
Day's Range | 0.4010 - 0.4500 |
52 Week Range | 0.3720 - 8.5000 |
Volume | |
Avg. Volume | 668,862 |
Market Cap | 25.313M |
Beta (5Y Monthly) | 1.77 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.0940 |
Earnings Date | Nov 02, 2022 - Nov 07, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.67 |
Aeglea (AGLE) delivered earnings and revenue surprises of -3.85% and 55.99%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
The recent setback faced by Acadia's (ACAD) resubmitted sNDA for Nuplazid (pimavanserin) for treating hallucinations and delusions associated with ADP has hurt the stock.